BMO Capital周一将Sarepta Therapeutics (NASDAQ:SRPT)的评级从"优于大市"下调至"与大市同步"，并将目标价从120.00美元大幅削减至70.00美元，此举是因为有报道称非行走患者在接受Elevidys治疗后出现第二例急性肝衰竭致死病例。该公司股票目前交易价格为36.18美元，过去六个月已下跌超过70%，尽管InvestingPro分析表明，在当前价位该股可 ...

The incident, reminiscent of Lewis Hamilton and Jenson Button's infamous clash at the same point in 2011, dealt a blow to Norris' title challenge. Piastri's points lead over his teammate now stands at ...